The lab develops and applies computational tools to study DNA and RNA aberrations that drive cancer and how these produce novel therapeutic opportunities.

We use bioinformatics and machine learning to characterize alterations in cancer cells and advance precision medicine for patients. Our methods can be applied to any tumor type, but we have special interest in cancers arising from immune cells and specifically chronic lymphocytic leukemia (CLL), a common B-cell leukemia.